MDT - Medtronic scores win in patent dispute with Axonics

The USPTO's Patent Trial and Appeal Board ((PTAB)) has rejected a request from Axonics Modulation Technologies ([[AXNX]] +2.2%) for a hearing to challenge the validity of U.S. Patent No. 9,463,324 ('324 patent) held by Medtronic ([[MDT]] +1.8%) covering technology related to implant recharging and temperature control. The PTAB stated that Axonics' argument lacked merit.The challenge to the '324 patent is the cornerstone of Axonics' challenge to seven Medtronic patents covering sacral modulation devices. The PTAB will allow a full inter partes review of the other six patents. A decision should be made within the next 12 months.

For further details see:

Medtronic scores win in patent dispute with Axonics